keyword
https://read.qxmd.com/read/38644119/laparoscopic-hepatectomy-for-hepatocellular-adenoma-using-the-hepatic-vein-as-anatomic-markers-how-i-do-it-with-video
#1
JOURNAL ARTICLE
Jie Huang, Dingwei Xu, Ao Li
TECHNIQUE: Hepatocellular adenoma (HCA) is a benign monoclonal tumour that originates from mature hepatocytes.Liver resection is recommended in case of overt malignant transformation to hepatocellular carcinoma.However, hepatobiliary surgeries are technically challenging in patients with giant HCA (GHCA) owing to the risk of catastrophic intraoperative bleeding and difficulty with its control during laparoscopic treatment. We present a technical note on the utilization of the hepatic vein as anatomical landmarks for laparoscopic removal of giant hepatic glands, without intraoperative ultrasonography and with the aid of an augmented reality navigation system during surgery...
April 20, 2024: Asian Journal of Surgery
https://read.qxmd.com/read/38631269/predicting-early-recurrence-after-resection-of-initially-unresectable-colorectal-liver-metastases-the-role-of-baseline-and-pre-surgery-clinical-radiological-and-molecular-factors-in-a-real-life-multicentre-experience
#2
JOURNAL ARTICLE
R Moretto, M M Germani, B Borelli, V Conca, D Rossini, P Boraschi, F Donati, L Urbani, S Lonardi, F Bergamo, K Cerma, G Ramondo, F E D'Amico, L Salvatore, G Valente, B Barbaro, F Giuliante, M Di Maio, G Masi, C Cremolini
BACKGROUND: Advances in surgical techniques and systemic treatments have increased the likelihood of achieving radical surgery and long-term survival in metastatic colorectal cancer (mCRC) patients with initially unresectable colorectal liver metastases (CRLMs). Nonetheless, roughly half of the patients resected after an upfront systemic therapy experience disease relapse within 6 months from surgery, thus leading to the question whether surgery is actually beneficial for these patients...
April 16, 2024: ESMO Open
https://read.qxmd.com/read/38586745/the-role-of-neoadjuvant-therapy-in-a-giant-gastric-gastrointestinal-stromal-tumour-a-case-report-and-review-of-the-literature
#3
Jolan S Alsaud, Saja Alruqayi, Abdulaziz Alomair
Gastric gastrointestinal stromal tumour (GIST) is a rare disease with an annual incidence of 10 cases per million. Herein, we present the case of a 45-year-old man who visited our clinic with complaints of weight loss and anorexia, without changes in bowel habits or vomiting, for four months. On physical examination, all vital signs were normal. The abdomen was distended without tenderness and had a giant upper abdominal mass. Tumour marker investigation revealed high levels of cancer antigen 125 with normal levels of alpha-1-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen...
March 2024: Curēus
https://read.qxmd.com/read/38585035/the-cea-pci-ratio-is-a-superior-prognosticator-than-mcorep-for-colorectal-cancer-patients-with-peritoneal-carcinomatosis
#4
JOURNAL ARTICLE
Phelopatir Anthony, Shoma Barat, Nima Ahmadi, David Lawson Morris
BACKGROUND: The CEA/PCI ratio, which evaluates tumour marker and burden, has been demonstrated as a prognosticator for patients with colorectal cancer with peritoneal carcinomatosis. The aim of this study was to compare the CEA/PCI ratio with the Modified Colorectal Peritoneal Score (mCOREP) for overall survival (OS) and recurrence free survival (RFS). There is no literature currently comparing both markers for RFS. METHODS: Data was collected retrospectively for patients undergoing CRS and hyperthermic intraperitoneal chemotherapy (HIPEC) at the Peritonectomy Unit at St...
June 2024: Surgery open science
https://read.qxmd.com/read/38578521/expression-of-cathepsin-d-in-early-stage-breast-cancer-and-its-prognostic-and-predictive-value
#5
JOURNAL ARTICLE
Inas Alhudiri, Christopher Nolan, Ian Ellis, Adam Elzagheid, Andrew Green, Caroline Chapman
PURPOSE: Cathepsin D is a proteolytic enzyme that is normally localized in the lysosomes and is involved in the malignant progression of breast cancer. There are conflicting results regarding Cathepsin D significance as prognostic and predictor marker in breast cancer. This study aimed to evaluate the expression and prognostic significance of Cathepsin D in early-stage breast cancer. METHODS: Expression of Cathepsin D was assessed by immunohistochemical staining of tissue microarrays, in a large well-characterized series of early-stage operable breast cancer (n = 954) from Nottingham Primary Breast Carcinoma Series between the period of 1988 and 1998 who underwent primary surgery...
April 5, 2024: Breast Cancer Research and Treatment
https://read.qxmd.com/read/38576939/gastric-myeloid-sarcoma-mimicking-pseudoachalasia-in-non-leukemic-context-a-singular-case-report
#6
Nidal Jebrini, Husein Sarahneh, Mohanad Jaber, Motaz Natsheh, Ahmad Abu Ayyash, Sami Bannoura, Raghad Razem
INTRODUCTION AND IMPORTANCE: Myeloid sarcoma (MS) is a rare tumour associated with acute myeloid leukaemia (AML) and occasionally occurs independently. It typically affects skin, bone, lymph nodes, and rarely the gastrointestinal tract, with gastric cases being extremely rare. Notably, no reported instances associate pseudoachalasia with gastric myeloid sarcoma. CASE PRESENTATION: A 20-year-old male presented with severe dysphagia, refractory vomiting, and weight loss...
April 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38568330/-testicular-tumor-in-a%C3%A2-9-year-old-boy
#7
JOURNAL ARTICLE
Abhay Raiyani, M Borisenkov, A Pandey
A 9-year-old boy presented to the emergency department after noticing a painless mass on the right testicle during self-examination in the shower. On physical examination, both testes were mobile and painless, with the right testis twice as big as the left and exhibiting palpable resistance. Sonographic examination revealed a uniformly demarcated mass with a ventral protrusion on the right testis. Tumor markers and blood tests were normal. The testis was exposed inguinally and the tumor was enucleated, which revealed a dermoid cyst...
April 3, 2024: Urologie
https://read.qxmd.com/read/38566933/double-immunohistochemical-labelling-of-prame-and-melan-a-in-slow-mohs-biopsy-margin-assessment-of-lentigo-maligna-and-lentigo-maligna-melanoma
#8
JOURNAL ARTICLE
R Salih, F Ismail, G E Orchard
Introduction: Lentigo maligna (LM) and lentigo maligna melanoma (LMM) predominantly affect the head and neck areas in elderly patients, presenting as challenging ill-defined pigmented lesions with indistinct borders. Surgical margin determination for complete removal remains intricate due to these characteristics. Morphological examination of surgical margins is the key form of determining successful treatment in LM/LMM and underpin the greater margin control provided through the Slow Mohs micrographic surgery (SMMS) approach...
2024: British Journal of Biomedical Science
https://read.qxmd.com/read/38538301/a-primary-cutaneous-carcinosarcoma-of-the-retro-auricular-region-how-to-treat-and-literature-review
#9
REVIEW
C Arkaz, J Pauwels, K Wetzels, B Cambier
INTRODUCTION: Carcinosarcomas are malignant biphasic tumours of epithelial and mesenchymal tissue. They are most often found in visceral organs, but also appear on the skin. Older age, male sex and chronic sun exposure are risk factors for its development. In this article we report a case and provide a review of literature regarding primary cutaneous carcinosarcoma (CCS) with special regard to its management. MATERIAL AND METHODS: A manual electronic search of the PubMed Medline and Web of Science Core Collection databases was performed encompassing all included reports until 30th November 2022 to identify studies that reported primary CCS...
2024: Acta Chirurgiae Plasticae
https://read.qxmd.com/read/38531576/efficacy-and-safety-of-natural-killer-cells-injection-combined-with-xelox-chemotherapy-in-postoperative-patients-with-stage-iii-colorectal-cancer-in-china-a-prospective-randomised-controlled-clinical-trial-study-protocol
#10
JOURNAL ARTICLE
Shan Geng, Xingrui Yu, Shaohong Yu
BACKGROUND: Colorectal cancer (CRC) is the second most frequently diagnosed cancer and the fifth leading cause of cancer-related death in China. However, resistance to multiple chemotherapeutics after surgery leads to failure of the main therapy to CRC. Natural killer (NK) cells are innate cytotoxic lymphocytes that exhibit strong cytotoxic activity against tumour cells. NK cell-based therapy, either alone or in combination with chemotherapy, has achieved favourable results and holds promise for addressing recurrence and metastasis in CRC patients after surgery...
March 25, 2024: BMJ Open
https://read.qxmd.com/read/38522881/curative-criteria-for-endoscopic-treatment-of-colorectal-cancer
#11
REVIEW
Lucille Quénéhervé, Mathieu Pioche, Jérémie Jacques
As endoscopic treatment enables en bloc resection of T1 colorectal cancers, the risk of recurrence, often assimilated to the risk of lymph node metastases, must be assessed in order to offer patients an additional treatment if this risk is deemed significant. The curative criteria currently used by most guidelines are depth of invasion <1 mm, well or moderately differentiated tumour, absence of lympho-vascular invasion, absence of significant budding and tumour-free resection margins. However, these factors must be assessed by qualified pathologists, as they are difficult to evaluate...
February 2024: Best Practice & Research. Clinical Gastroenterology
https://read.qxmd.com/read/38508617/feasibility-study-of-a-multimodal-prehabilitation-programme-in-women-receiving-neoadjuvant-therapy-for-breast-cancer-in-a-major-cancer-hospital-a-protocol
#12
JOURNAL ARTICLE
Suzanne J Grant, Shelley Kay, Judith Lacey, Sanjeev Kumar, Kim Kerin-Ayres, Justine Stehn, Maria Gonzalez, Sandra Templeton, Gillian Heller, Jane Cockburn, Sara Wahlroos, Ashanya Malalasekera, Cindy Mak, Susannah Graham
INTRODUCTION: Neoadjuvant therapy has become a standard treatment for patients with stage II/III HER2 positive and triple negative breast cancer, and in well-selected patients with locally advanced and borderline resectable high risk, luminal B breast cancer. Side effects of neoadjuvant therapy, such as fatigue, cardiotoxicity, neurotoxicity, anxiety, insomnia, vasomotor symptoms, gastrointestinal disturbance as well as a raft of immune-related adverse events, may impact treatment tolerance, long-term outcomes, and quality of life...
March 20, 2024: BMJ Open
https://read.qxmd.com/read/38481180/predictive-effect-of-the-systemic-inflammation-response-index-siri-on-the-efficacy-and-prognosis-of-neoadjuvant-chemoradiotherapy-in-patients-with-locally-advanced-rectal-cancer
#13
JOURNAL ARTICLE
Yuanyi Ding, Zining Liu, Jing Li, Wenbo Niu, Chenhui Li, Bin Yu
BACKGROUND: Inflammation is a part of tumours, and inflammatory cells can affect the proliferation, invasion, and development of tumour cells. An increasing number of peripheral blood inflammatory markers have been found to play very important roles in the treatment and prognosis of cancer patients. The systemic inflammatory response index (SIRI) is a newer inflammatory marker, and its role in colorectal cancer, especially in locally advanced rectal cancer, is still unclear. METHODS: From 2015 to 2020, 198 patients with locally advanced rectal cancer (LARC) who underwent surgery following neoadjuvant chemoradiotherapy (Neo-CRT) were analysed...
March 13, 2024: BMC Surgery
https://read.qxmd.com/read/38476302/embryonal-sarcoma-of-the-liver-in-the-adult-challenges-in-the-diagnosis-of-a-rare-entity
#14
JOURNAL ARTICLE
Guilherme Nogueira Fontinha, João Martins Gama, Rui Caetano Oliveira, Augusta Cipriano
INTRODUCTION: Embryonal sarcoma of the liver (ESL) is a rare neoplasm of the liver occurring mainly in paediatric ages. Making the correct diagnosis can be challenging as the laboratory and radiological findings that are often nonspecific, and the tumour immunophenotype is poorly defined and even somewhat variable. CASE PRESENTATION: A large epigastric mass was detected in a computerized tomography scan of a 43-year-old woman presenting with abdominal pain and bloating...
February 2024: GE Portuguese Journal of Gastroenterology
https://read.qxmd.com/read/38464388/novel-therapeutic-strategies-targeting-myeloid-derived-suppressor-cell-immunosuppressive-mechanisms-for-cancer-treatment
#15
REVIEW
Eric Jou, Natasha Chaudhury, Fizza Nasim
Cancer is the leading cause of death globally superseded only by cardiovascular diseases, and novel strategies to overcome therapeutic resistance against existing cancer treatments are urgently required. Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with potent immunosuppressive capacity against well-established anti-tumour effectors such as natural killer cells (NK cells) and T cells thereby promoting cancer initiation and progression. Critically, MDSCs are readily identified in almost all tumour types and human cancer patients, and numerous studies in the past decade have recognised their role in contributing to therapeutic resistance against all four pillars of modern cancer treatment, namely surgery, chemotherapy, radiotherapy and immunotherapy...
2024: Exploration of targeted anti-tumor therapy
https://read.qxmd.com/read/38463069/crocin-inhibit-the-metastasis-of-mda-mb-231-cell-line-by-suppressing-epithelial-to-mesenchymal-transition-through-wnt-%C3%AE-catenin-signalling-pathway
#16
JOURNAL ARTICLE
Vajihe Ghorbanzadeh, Karwan Anwar Hassan Aljaf, Hunar Mustafa Wasman, Hassan Dariushnejad
BACKGROUND: Triple-negative breast cancer has the poorest prognosis and survival rates compared to other breast cancer subtypes due to its invasive behaviours. This type of cancer does not respond to biological therapies and exhibits resistance to available treatment options. Therefore, it is imperative to discover new therapeutics to address this challenge. METHODS: In this study, a TNBC cell line was utilized to investigate the anti-metastatic effect of crocin on the Wnt/β-catenin pathway...
March 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38463066/marker-controlled-watershed-algorithm-and-fuzzy-c-means-clustering-machine-learning-automated-segmentation-of-glioblastoma-from-mri-images-in-a-case-series
#17
JOURNAL ARTICLE
Sadegh Ghaderi, Sana Mohammadi, Kayvan Ghaderi, Fereshteh Kiasat, Mahdi Mohammadi
INTRODUCTION AND IMPORTANCE: Automated segmentation of glioblastoma multiforme (GBM) from MRI images is crucial for accurate diagnosis and treatment planning. This paper presents a new and innovative approach for automating the segmentation of GBM from MRI images using the marker-controlled watershed segmentation (MCWS) algorithm. CASE PRESENTATION AND METHODS: The technique involves several image processing techniques, including adaptive thresholding, morphological filtering, gradient magnitude calculation, and regional maxima identification...
March 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38443233/a-potential-new-biomarker-in-hnscc-metastasis-suppressor-protein-1-mtss1
#18
JOURNAL ARTICLE
Maurice Klein, Kai Wermker, Ashkan Rashad, Henrike J Fischer, Danny D Jonigk, Frank Hölzle, Claudio Cacchi
OBJECTIVE: Metastasis suppressor protein 1 (MTSS1) is a prognostic tumour marker in different malignant epithelial tumour entities and previously mainly the MTSS1 expression was analysed. This study evaluated the best analysis method as a prognosis and aggressiveness tumour marker in head and neck squamous cell carcinoma (HNSCC). STUDY DESIGN: MTSS1 expression, MTSS1 intensity, interpretation MTSS1 score and MTSS1 edging score were analysed in formalin-fixed paraffin-embedded tissue slices of 60 patients with proven HNSCC and correlated with clinical and pathological outcome parameters...
January 11, 2024: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
https://read.qxmd.com/read/38441331/deciphering-the-tumour-immune-microenvironment-of-hepatocellular-carcinoma
#19
REVIEW
Sha Liu, Man Jia, Rongyang Dai
Current treatments for hepatocellular carcinoma (HCC) are less effective and prone to recurrence after surgery, so it's needed to seek new ideas for its therapy. Tumour immune microenvironment (TME) is crucial for the pathogenesis, development and metastasis of HCC. Interactions between immune cells and tumour cells significantly impact responses to immunotherapies and patient prognosis. In recent years, immunotherapies for HCC have shown promising potential, but the response rate is still unsatisfactory. Understanding their cross-talks is helpful for selecting potential therapeutic targets, predicting immunotherapy responses, determining immunotherapy efficacy, identifying prognostic markers and selecting individualized treatment options...
November 2023: Scandinavian Journal of Immunology
https://read.qxmd.com/read/38440492/a-prospective-study-between-molecular-marker-p53-analysis-and-hpe-for-tumour-positivity-in-primary-resected-margins-in-head-and-neck-squamous-cell-carcinoma
#20
JOURNAL ARTICLE
Ashok Poonia, Anjani Sharma, Neelam Meena, Shivam Sharma, Aakanksha Dadhich
Head and neck malignancies are the seventeenth most common malignancies, worldwide and second most common malignancy in India. So current study aims to compare between molecular marker p53 analysis and HPE for tumour positivity in primary resected margins in head and neck SCC. 61 patients with head and neck SCC were included in this prospective observational cross-sectional study performed in tertiary care hospital. A detailed history general physical examination blood investigation was done before the surgery...
February 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
keyword
keyword
13162
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.